• Spleen-Targeted Neoantigen mRNA Vaccine Drives TLS in HCC

  2026-05-19

  Lin et al. developed a spleen-targeted neoantigen mRNA vaccine (STNvac) that induces potent antitumor immunity in hepatocellular carcinoma (HCC) by activating ISG15+ CD8+ T cells and promoting tertiary lymphoid structure (TLS) formation. The study reveals mechanistic links between vaccine delivery, immune cell activation, and tumor regression, offering new directions for mRNA vaccine design in immune-refractory cancers.

• Tropifexor (LJN452): Applied Protocols for FXR Pathway Resea

  2026-05-18

  Tropifexor (LJN452) empowers researchers to precisely modulate the FXR signaling pathway, advancing studies in metabolic and intestinal epithelial barrier function. This guide delivers experiment-ready workflows, troubleshooting insights, and practical protocol enhancements—all grounded in the latest evidence and real-world laboratory scenarios.

• Silybin A (SKU N1711): Reliable Solutions for Cell Assays

  2026-05-18

  This article addresses core laboratory challenges in cell viability, proliferation, and cytotoxicity assays by presenting evidence-based solutions using Silybin A (SKU N1711). Drawing on peer-reviewed research and APExBIO’s product dossier, it guides biomedical researchers in optimizing reproducibility, sensitivity, and workflow safety with Silybin A in metabolic and liver disease contexts.

• Applied Use of EZ Cap EGFP mRNA 5-moUTP in Gene Expression A

  2026-05-17

  EZ Cap™ EGFP mRNA (5-moUTP) delivers robust, low-immunogenicity fluorescent reporter expression for gene regulation, translation efficiency, and in vivo imaging applications. This guide details practical workflows and troubleshooting strategies to maximize reproducibility and sensitivity, leveraging the latest advances in mRNA delivery and stability engineering.

• MLN4924: Decoding NEDD8 Pathway Inhibition for Cancer Resear

  2026-05-16

  Explore how MLN4924, a potent NEDD8-activating enzyme inhibitor, revolutionizes cancer biology research by enabling precise dissection of neddylation pathways. This in-depth analysis highlights novel insights into E3 ligase regulation and practical assay design.

• Solving Cytoskeletal Assay Challenges with (-)-Blebbistatin

  2026-05-15

  This scenario-driven article addresses common laboratory challenges in cytoskeletal and cell viability assays, demonstrating how (-)-Blebbistatin (SKU B1387) offers validated, reproducible solutions for non-muscle myosin II inhibition. By integrating real-world Q&A, protocol parameters, and comparative analysis, we guide biomedical researchers towards more reliable, interpretable, and cost-efficient workflows.

• p-Cresyl Sulfate: Molecular Insights into Uremic Toxin Signa

  2026-05-15

  Explore the molecular mechanisms by which p-Cresyl sulfate drives cardiovascular risk in CKD, with a focus on klotho/SIRT1 signaling and assay design. This article provides a unique, mechanistically deep analysis distinct from existing protocol guides.

• Translational mRNA Engineering: Polyadenylation for Next-Gen

  2026-05-14

  This thought-leadership article explores how robust, controlled polyadenylation using the HyperScribe™ Poly (A) Tailing Kit empowers translational researchers to fine-tune mRNA stability and translation efficiency. We bridge mechanistic insight with strategic guidance, contextualized by recent breakthroughs in mRNA therapy for thrombopoiesis. The discussion also benchmarks the kit against the competitive landscape and provides actionable parameters for optimal experimental design.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays

  2026-05-14

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers robust, reproducible bioluminescent reporter signals for gene regulation and mRNA delivery studies. Its advanced stabilizing features enable high-sensitivity in vivo imaging and efficient translation, making it an ideal platform for next-generation molecular biology workflows.

• DMG-PEG2000-NH2: Precision Linker Chemistry in Next-Gen LNPs

  2026-05-13

  Explore how DMG-PEG2000-NH2, a leading NH2-PEG derivative, advances lipid nanoparticle (LNP) formulation and targeted drug delivery. This article uncovers mechanistic insights and assay optimization strategies not covered elsewhere.

• Heterologous Regulatory Gene Impact on A40926 Antibiotic Pro

  2026-05-13

  This study investigates how StrR-like regulatory genes from distant lipodepsipeptide biosynthetic clusters modulate the production of glycopeptide antibiotics, including A40926, the precursor to dalbavancin. The findings reveal that certain heterologous regulators can enhance antibiotic yields, providing new strategies for activating silent gene clusters and optimizing glycopeptide production.

• Lipid Nanoparticles Enable ABE8e Correction of COL7A1 in DEB

  2026-05-12

  This study demonstrates the efficient delivery of adenine base editor ABE8e using lipid nanoparticles to correct COL7A1 mutations in dystrophic epidermolysis bullosa fibroblasts. The findings offer a promising, non-viral approach for gene correction in inherited skin diseases and guide the use of reporter mRNA technologies in similar delivery workflows.

• In Vitro Activity of Temafloxacin Against Gram-Negative Bact

  2026-05-12

  This article details the in vitro potency of Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, against Gram-negative pathogens. The reference study provides comparative MIC data versus other fluoroquinolones and discusses implications for research on resistant and atypical bacterial infections.

• Spleen-Targeted mRNA Vaccines Drive Antitumor TLS in HCC Mod

  2026-05-11

  Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine (STNvac) that robustly activates ISG15+ CD8+ T cells and induces tertiary lymphoid structure formation in hepatocellular carcinoma (HCC). Their work delineates a mechanism of GZMA-F2R-mediated immune cell crosstalk and opens new avenues for organ-targeted mRNA vaccine design against solid tumors.

• 40-Hz Light Flicker Promotes Retinal Amyloid Clearance via M

  2026-05-11

  This study demonstrates that 40-Hz light flicker enhances the clearance of amyloid-β (Aβ) in the retina by upregulating MHC-II expression in microglia. The research highlights a non-invasive strategy for addressing metabolic waste buildup in age-related retinal disorders, with mechanistic insights into microglial activation and its modulation by minocycline hydrochloride.

622 records 14/42 page Previous Next First page 上5页 1112131415 下5页 Last page